Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07069179Not ApplicableRecruiting

Feasibility of Choose to Move Replacement Ready

Role: collaborator

NCT06252259Not ApplicableEnrolling By Invitation

Evaluating Implementation and Impact of the Adapted Choose to Move (CTM) Program

Role: collaborator

NCT05678985Not ApplicableCompleted

Evaluating Impact and Implementation of Choose to Move (Phase 4)

Role: collaborator

NCT04592614Not ApplicableCompleted

Choose to Move - Next Steps: Can 'Booster Sessions' Sustain Health Benefits of an Effective, Scaled-up, Health Promotion Program?

Role: collaborator

NCT05497648Not ApplicableCompleted

Evaluating Impact and Implementation of Choose to Move (Phase 3)

Role: collaborator

All 5 trials loaded